Protara Therapeutics held its Annual Meeting of Stockholders on June 7, 2024, where stockholders voted on various proposals including the election of directors, ratification of the selection of an independent registered public accounting firm, approval of executive compensation, and approval of equity incentive and employee stock purchase plans.